Time Restricted Feeding, Muscle, and Metabolism

NCT ID: NCT04949451

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-13

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not emerged. This study uses time restricted feeding to study the role of dietary protein in obesity prevention and/or treatment. The objectives are to determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and peripheral signals that regulate appetite and energy intake in overweight and obese adults and to determine the effects of protein timing on muscle mass to regulate appetite and energy intake in overweight and obese adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overweight Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TRF-C

Follows time restricted feeding protocol.

Group Type PLACEBO_COMPARATOR

Control group - time restricted feeding only

Intervention Type OTHER

Time restricted feeding.

TRF-P

Follows time restricted feeding protocol, consumes protein supplement

Group Type EXPERIMENTAL

Whey protein supplement

Intervention Type DIETARY_SUPPLEMENT

Participants consume whey protein at the beginning of the eating period.

TRF-S

Follows time restricted feeding protocol, consumes ketogenic supplement

Group Type EXPERIMENTAL

Ketogenic aid

Intervention Type DIETARY_SUPPLEMENT

Participants consume ketogenic aid upon waking.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whey protein supplement

Participants consume whey protein at the beginning of the eating period.

Intervention Type DIETARY_SUPPLEMENT

Ketogenic aid

Participants consume ketogenic aid upon waking.

Intervention Type DIETARY_SUPPLEMENT

Control group - time restricted feeding only

Time restricted feeding.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Resides in Northwest Arkansas
* Age 25-50 years
* BMI \> 25
* All ethnicities
* Female and male

Exclusion Criteria

* Food allergies
* Pregnant or breastfeeding
* Dietary restrictions (e.g. vegetarian, vegan, etc.)
* Trying to lose weight in last 3 months
* Pre-existing health conditions related to obesity (e.g. cardiovascular disease, diabetes, hypertension)
* Prescription medications related to heart disease or type 2 diabetes
* Fear of needles
* Smoker or vaping
* Currently taking protein supplements or other nutritional supplements which may interfere with study outcomes
* Consumes \>4 alcoholic beverages per week
Minimum Eligible Age

25 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Arkansas, Fayetteville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jamie Baum

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arkansas

Fayetteville, Arkansas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jamie Baum, PhD

Role: CONTACT

479-575-4474

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jamie I Baum, PhD

Role: primary

479-575-4474

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TRIMM062021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.